Endometrial cancer and obesity. (4th September 2019)

• Record Type: Journal Article
• Authors: Kitson, Sarah J; Crosbie, Emma J
• Is Part Of: Obstetrician & gynaecologist. Volume 21:Number 4(2019)
• Page Start: 237
• Page End: 245
• Publication Date: 2019-09-04
• Subjects: cardiovascular disease risk -- endometrial cancer -- levonorgestrel‐releasing intrauterine system (LNG‐IUS) -- obesity -- weight loss; Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1111/tog.12601
• Languages: English
• ISSNs: 1467-2561

Abstract

Abstract : Key content: Of the 20 most common tumour types, endometrial cancer has the strongest association with obesity. Endometrial cancer should be considered in young, obese women with irregular or heavy menstrual bleeding. To reduce the risk of postoperative complications, surgery for endometrial cancer should be performed using minimal access techniques whenever possible. For women who are unfit for, or who decline, surgery, alternative treatments include progestins or radiotherapy, but these have lower efficacy and are associated with a higher risk of disease relapse. Obesity is associated with reduced overall survival following endometrial cancer because of increased cardiovascular mortality; it may also affect disease‐specific survival. Learning objectives: To further understanding of the mechanisms through which obesity drives endometrial carcinogenesis. To improve understanding of the potential difficulties associated with the management of endometrial cancer in obese women. To increase knowledge of alternative treatment options for women who are unfit for, or who decline, standard endometrial cancer management. Ethical issues: The number of young, premenopausal women with endometrial cancer is increasing – how should these women be managed? Should super‐obese women with endometrial cancer only be treated in cancer centres? After treating a woman's endometrial cancer, how should she be counselled her about her weight and cardiovascular disease risk?